Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 27

1.

Buprenorphine.

Lewis JW.

Drug Alcohol Depend. 1985 Feb;14(3-4):363-72. Review.

PMID:
2986930
2.

Nalbuphine.

Schmidt WK, Tam SW, Shotzberger GS, Smith DH Jr, Clark R, Vernier VG.

Drug Alcohol Depend. 1985 Feb;14(3-4):339-62. Review.

PMID:
2986929
3.

Behavioral pharmacology of buprenorphine.

Mello NK, Mendelson JH.

Drug Alcohol Depend. 1985 Feb;14(3-4):283-303. Review.

PMID:
3888577
4.

Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).

Pergolizzi J, Böger RH, Budd K, Dahan A, Erdine S, Hans G, Kress HG, Langford R, Likar R, Raffa RB, Sacerdote P.

Pain Pract. 2008 Jul-Aug;8(4):287-313. doi: 10.1111/j.1533-2500.2008.00204.x. Epub 2008 May 23.

PMID:
18503626
5.

Review of self-administration.

Balster RL, Lukas SE.

Drug Alcohol Depend. 1985 Feb;14(3-4):249-61. Review.

PMID:
3888576
6.

Buprenorphine: new pharmacological aspects.

Cowan A.

Int J Clin Pract Suppl. 2003 Feb;(133):3-8; discussion 23-4. Review.

PMID:
12665117
7.
8.
9.

Buprenorphine treatment of opiate and cocaine abuse: clinical and preclinical studies.

Mello NK, Mendelson JH, Lukas SE, Gastfriend DR, Teoh SK, Holman BL.

Harv Rev Psychiatry. 1993 Sep-Oct;1(3):168-83. Review.

PMID:
9384844
10.

Buprenorphine: considerations for pain management.

Johnson RE, Fudala PJ, Payne R.

J Pain Symptom Manage. 2005 Mar;29(3):297-326. Review.

PMID:
15781180
11.

Behavioral characterization of opioid mixed agonist-antagonists.

Woods JH, Winger G.

Drug Alcohol Depend. 1987 Dec;20(4):303-15. Review.

12.

Buprenorphine: a primer for emergency physicians.

Sporer KA.

Ann Emerg Med. 2004 May;43(5):580-4. Review.

13.

Opioid ligands having delayed long-term antagonist activity: potential pharmacotherapies for opioid abuse.

Husbands SM, Lewis JW.

Mini Rev Med Chem. 2003 Mar;3(2):137-44. Review.

PMID:
12570846
14.

Partial versus full agonists for opioid-mediated analgesia--focus on fentanyl and buprenorphine.

Zuurmond WW, Meert TF, Noorduin H.

Acta Anaesthesiol Belg. 2002;53(3):193-201. Review.

PMID:
12461829
15.

Buprenorphine as a pharmacotherapy for cocaine abuse: a review of the evidence.

Compton PA, Ling W, Charuvastra VC, Wesson DR.

J Addict Dis. 1995;14(3):97-114. Review.

PMID:
8555282
16.

[Opiate receptors].

Latasch L, Christ R.

Anaesthesist. 1986 Feb;35(2):55-65. Review. German.

PMID:
2870660
17.

Assessment of buprenorphine in a drug discrimination procedure in humans.

Bigelow GE, Preston KL.

NIDA Res Monogr. 1992;121:28-37. Review.

PMID:
1406908
18.

Behavioral pharmacology of buprenorphine, with a focus on preclinical models of reward and addiction.

Tzschentke TM.

Psychopharmacology (Berl). 2002 Apr;161(1):1-16. Epub 2002 Mar 6. Review.

PMID:
11967625
19.

Buprenorphine: a review of its pharmacological properties and therapeutic efficacy.

Heel RC, Brogden RN, Speight TM, Avery GS.

Drugs. 1979 Feb;17(2):81-110. Review.

PMID:
378645
20.

Buprenorphine: a unique opioid with broad clinical applications.

Vadivelu N, Hines RL.

J Opioid Manag. 2007 Jan-Feb;3(1):49-58. Review.

PMID:
17367094

Supplemental Content

Support Center